Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions

Details for Australian Patent Application No. 2001286798 (hide)

Owner Somerset Pharmaceuticals, Inc.

Inventors Disanto, Anthony R.; Blume, Cheryl D.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001286798

PCT Pub. Number WO02/19964

Priority 60/228,431 28.08.00 US

Filing date 27 August 2001

Wipo publication date 22 March 2002

Acceptance publication date 17 May 2007

International Classifications

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

Event Publications

17 May 2007 Application Accepted

  Published as AU-B-2001286798

13 September 2007 Standard Patent Sealed

24 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001286799-Providing secure network access for short-range wireless computing devices

2001286797